or Try an Advanced Search...

    Technical Analysis for ONCY - Oncolytics Biotech Inc.

    Grade Last Price % Change Price Change
    C 1.18 -0.84% -0.01
    ONCY closed down 0.84 percent on Wednesday, May 8, 2024, on 32 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical ONCY trend table...
    Date Alert Name Type % Chg
    Stochastic Sell Signal Bearish 0.00%
    Inside Day Range Contraction 0.00%
    Overbought Stochastic Strength 0.00%
    Gapped Down Weakness 0.00%
    Gapped Up Strength -0.84%
    Overbought Stochastic Strength -0.84%
    Earnings Movers Other 0.00%
    Gapped Up Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Older End-of-Day Signals for ONCY ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 13 hours ago
    60 Minute Opening Range Breakdown about 14 hours ago
    Down 3% about 14 hours ago
    Down 2 % about 14 hours ago
    Gap Down Partially Closed about 17 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ONCY Chart by TradingView
    Basic chart:

    Profile

    Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Treatment Of Cancer Pharmaceutical Products Oncolytics Biotech Synbio

    Is ONCY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 Oncolytics Biotech Q1 2024 Earnings Preview
    May 8 Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
    Apr 30 Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
    Apr 25 Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
    Apr 11 Oncolytics seeking FDA meeting to discuss registration-enabling study
    Apr 11 Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
    Apr 2 Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference
    Mar 10 Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript
    Mar 9 Oncolytics Biotech, Inc. (ONCY) Q4 2023 Earnings Call Transcript
    Mar 7 Oncolytics Biotech GAAP EPS of -$0.05 beats by $0.06
    See more ONCY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.3942
    52 Week Low 0.883
    Average Volume 289,212
    200-Day Moving Average 1.53
    50-Day Moving Average 1.08
    20-Day Moving Average 1.11
    10-Day Moving Average 1.14
    Average True Range 0.06
    RSI (14) 63.50
    ADX 20.26
    +DI 22.69
    -DI 12.17
    Chandelier Exit (Long, 3 ATRs) 1.03
    Chandelier Exit (Short, 3 ATRs) 1.18
    Upper Bollinger Bands 1.21
    Lower Bollinger Band 1.00
    Percent B (%b) 0.86
    BandWidth 18.86
    MACD Line 0.03
    MACD Signal Line 0.02
    MACD Histogram 0.0114
    Fundamentals Value
    Market Cap 86.61 Million
    Num Shares 73.4 Million
    EPS -0.38
    Price-to-Earnings (P/E) Ratio -3.11
    Price-to-Sales 0.00
    Price-to-Book 3.58
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.24
    Resistance 3 (R3) 1.24 1.21 1.23
    Resistance 2 (R2) 1.21 1.20 1.21 1.23
    Resistance 1 (R1) 1.20 1.19 1.20 1.20 1.22
    Pivot Point 1.17 1.17 1.18 1.18 1.17
    Support 1 (S1) 1.16 1.16 1.17 1.16 1.14
    Support 2 (S2) 1.13 1.15 1.14 1.13
    Support 3 (S3) 1.12 1.13 1.13
    Support 4 (S4) 1.12